These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35600955)

  • 1. Integrated Network Pharmacology and Clinical Study to Reveal the Effects and Mechanisms of Bushen Huoxue Huatan Decoction on Polycystic Ovary Syndrome.
    Ding J; Shanshan M; Mengcheng C; Danying Z; Jin Y
    Evid Based Complement Alternat Med; 2022; 2022():2635375. PubMed ID: 35600955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
    Yu J; Fu Y; Zeng L; Zheng Y
    Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial.
    Qian H; Xu W; Cui L; Wang R; Wang J; Tang M; Wei M; Wang L
    Trials; 2021 Nov; 22(1):781. PubMed ID: 34743745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of
    Ma JX; Ye M; Ma K; Zhou K; Zhang Y; Wang X; Tong H
    Evid Based Complement Alternat Med; 2021; 2021():6651307. PubMed ID: 34457027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
    Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
    J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total flavonoids extracted from
    Zhou Y; Lv L; Liu Q; Song J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30463907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yishen Huatan Huoxue decoction and quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: A comprehensive investigation combining clinical trial and experimental studies.
    Wang J; Li L; Zhou J; Pan X; Qi Q; Sun H; Wang L
    Drug Discov Ther; 2024 Jun; 18(2):117-129. PubMed ID: 38644207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology.
    Zhang YY; Ma JX; Zhu YT; Wang YX; Chen WQ; Sun X; Zhang W; Wang CY; Ding CF
    J Ovarian Res; 2022 Apr; 15(1):40. PubMed ID: 35379295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
    Ma K; Gong LJ; Chen YX; Tian CD
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome.
    Cai YL; Zhang F; Dou XX; Zeng HW; Wu GS; Liang YL; Xu XK; Zhao J; Ye J; Zhang WD
    J Ethnopharmacol; 2022 Sep; 295():115442. PubMed ID: 35688255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
    Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Mechanism of Wenshen Huatan Quyu Decotion for PCOS Based on Network Pharmacology and Molecular Docking Verification.
    Guo X; Xu Y; Sun J; Wang Q; Kong H; Zhong Z
    Stem Cells Int; 2022; 2022():3299091. PubMed ID: 36071733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology.
    Lin Y; Xiang L; Li X; Tang Q; Meng F; Chen W
    Curr Med Chem; 2023; 30(21):2463-2474. PubMed ID: 35532255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the molecular targets and mechanism of
    Yu H; Zhang L; Yin F; Zhan C; Chen J; Chu J
    Ann Transl Med; 2023 Feb; 11(3):149. PubMed ID: 36846000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network Pharmacology Combined with Molecular Docking and Experimental Verification Reveals the Bioactive Components and Potential Targets of Danlong Dingchuan Decoction against Asthma.
    Xue B; Zhao Q; Chen D; Wang X; Li L; Li J; Tian J
    Evid Based Complement Alternat Med; 2022; 2022():7895271. PubMed ID: 35186104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology.
    Xu W; Tang M; Wang J; Wang L
    Evid Based Complement Alternat Med; 2020; 2020():4086864. PubMed ID: 32148541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.
    Li WH; Han JR; Ren PP; Xie Y; Jiang DY
    Comput Biol Chem; 2021 Feb; 90():107358. PubMed ID: 33243703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bushen Jieyu Tiaochong Formula reduces apoptosis of granulosa cells via the PERK-ATF4-CHOP signaling pathway in a rat model of polycystic ovary syndrome with chronic stress.
    Pan X; Liu Y; Liu L; Pang B; Sun Z; Guan S; Yan Q; Mo T; Chen R; Xu M; Chang Z; Zhou X
    J Ethnopharmacol; 2022 Jun; 292():114923. PubMed ID: 34923086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of microRNA-409 on the pathogenesis of polycystic ovary syndrome.
    Teng YL; Lin SY; Yang HY; Meng LH; Yu R; Zeng LC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1874-1881. PubMed ID: 30915729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.